Combination therapy in kidney cancer: the next revolution?

Lancet Oncol. 2015 Nov;16(15):1441-1442. doi: 10.1016/S1470-2045(15)00325-3. Epub 2015 Oct 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary*
  • Everolimus / administration & dosage*
  • Female
  • Humans
  • Kidney Neoplasms / pathology*
  • Male
  • Phenylurea Compounds / administration & dosage*
  • Quinolines / administration & dosage*

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Quinolines
  • Everolimus